Search

everythinglearnresearchcommunity

for

Search:↓

Both finasteride and metformin effectively treat PCOS by reducing hormone levels and insulin resistance.

Spinach-derived thylakoid supplements plus a low-calorie diet helped obese women with polycystic ovary syndrome lose weight and improve their metabolism.

Early hair greying may increase the risk of heart disease.

The most common skin issues in females with Polycystic Ovary Syndrome (PCOS) are excessive hair growth, hair loss, oily skin, acne, dark skin patches, and skin tags, which may be linked to hormone and insulin levels.

Men with early hair loss may have higher risks of insulin resistance and metabolic issues.

PCOS is the main cause of hirsutism, often linked to insulin resistance.

Overweight women with PCOS are more likely to have excess male hormones.

Oxidative stress is higher in women with PCOS, especially if they're obese, and it may increase their risk of heart disease.

High Nesfatin-1 and low Vitamin D may increase blood pressure and heart rate in women with PCOS.

High uric acid levels are more common in PCOS patients, especially those with androgenic PCOS, and are linked with increased cardiovascular risk and other metabolic issues.

Lower baseline prolactin levels may lead to better insulin resistance improvement with metformin in PCOS patients.

PCOS is linked to chronic low-grade inflammation, but the role of certain infections is unclear.

Women with female pattern hair loss may have a higher risk of metabolic syndrome.

Women with Polycystic Ovary Syndrome are more likely to have Non-Alcoholic Fatty Pancreas Disease, which is associated with older age, metabolic syndrome, insulin resistance, and high male hormone levels.

Women with Polycystic Ovary Syndrome (PCOS) have lower levels of a substance called DIAPH1 in their blood, which is linked to changes in sugar metabolism and insulin resistance.

Obese women with PCOS have more cardiovascular risk factors, and waist-to-stature ratio is a better health marker than waist-to-hip ratio.

Different PCOS characteristics affect lipid profiles, increasing cardiovascular disease risk, so regular lipid screening is advised.

A very-low-calorie diet led to more weight loss and health improvements in obese women with PCOS than a moderate energy deficit diet.

Managing oxidative stress might help treat low testosterone and related chronic diseases in aging men.

High levels of male hormones and irregular periods best predict how well PCOS patients will respond to metformin treatment.

Personalized diets, like the Mediterranean Diet and low carb diets, can help manage PCOS symptoms in obese women, and probiotics may enhance weight loss and improve metabolic health. More research is needed to find the best diet strategies.

Metformin is less effective in men with early-onset hair loss.

Weight loss improves PCOS symptoms and overall health.

Clinical signs of hyperandrogenism are related to female pattern hair loss severity, but biochemical markers are not.

Addressing body image and weight can help improve female sexual dysfunction.

Male relatives of women with PCOS show similar health issues, suggesting a male version of the condition.

Genetic risk for PCOS can affect children's growth, metabolism, and development from early life into adulthood.

Lipid Accumulation Product and Free Androgens Index are effective for assessing fatty liver disease risk in women with Polycystic Ovary Syndrome.

People with androgenetic alopecia, both men and women, are more likely to develop heart diseases in the future.

Metformin is effective for treating excessive hair growth in women with PCOS and may work better than the standard treatment in some ways.